Literature DB >> 1837284

Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor.

G Sarkar1, S Kapelner, D K Grandy, M Marchionni, O Civelli, J Sobell, L Heston, S S Sommer.   

Abstract

The dopamine D2 receptor gene (gene symbol DRD2) is a candidate gene for schizophrenia because the potency of certain neuroleptics correlates with their affinity for this receptor. Seven regions of likely functional significance including the coding sequences and the splice junctions were fully sequenced in the dopamine D2 receptor of 14 schizophrenics (and partially in several others) meeting DSM-III-R diagnostic criteria and in four unaffected non-Caucasians (97 kb of total sequence). No structural changes were found, suggesting that alteration in the structure of the dopamine D2 receptor is not commonly involved in the etiology of schizophrenia. However, two common and one uncommon intragenic polymorphisms were found. At least one of the polymorphisms was informative for linkage in 70% of Caucasians and 78% of Koreans.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1837284     DOI: 10.1016/0888-7543(91)90096-w

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  14 in total

1.  Association of a missense change in the D2 dopamine receptor with myoclonus dystonia.

Authors:  C Klein; M F Brin; P Kramer; M Sena-Esteves; D de Leon; D Doheny; S Bressman; S Fahn; X O Breakefield; L J Ozelius
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 2.  Dopamine receptor genes: new tools for molecular psychiatry.

Authors:  H B Niznik; H H Van Tol
Journal:  J Psychiatry Neurosci       Date:  1992-10       Impact factor: 6.186

3.  PharmGKB summary: dopamine receptor D2.

Authors:  Huaiyu Mi; Paul D Thomas; Huijun Z Ring; Ruhong Jiang; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-06       Impact factor: 2.089

4.  From molecular variant to disease: initial steps in evaluating the association of transthyretin M119 with disease.

Authors:  S Ii; J L Sobell; S S Sommer
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

5.  A new polymorphism in the gene for the dopamine D2 receptor.

Authors:  S E Poduslo; J Schwankhaus
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

6.  Predictive index for the onset of medication overuse headache in migraine patients.

Authors:  T Onaya; M Ishii; H Katoh; S Shimizu; H Kasai; M Kawamura; Y Kiuchi
Journal:  Neurol Sci       Date:  2013-01       Impact factor: 3.307

7.  Negative predictors of clinical response to triptans in patients with migraine.

Authors:  M Ishii; Y Sakairi; H Hara; A Imagawa; S Shimizu; J Takahashi; A Nagamine; Y Naito; Y Masuda; S Usami; Y Kiuchi
Journal:  Neurol Sci       Date:  2011-08-06       Impact factor: 3.307

8.  MAOA, MTHFR, and TNF-β genes polymorphisms and personality traits in the pathogenesis of migraine.

Authors:  Masakazu Ishii; Shunichi Shimizu; Yuki Sakairi; Ayumu Nagamine; Yuika Naito; Yukiko Hosaka; Yuko Naito; Tatsuya Kurihara; Tomomi Onaya; Hideto Oyamada; Atsuko Imagawa; Kenji Shida; Johji Takahashi; Katsuji Oguchi; Yutaka Masuda; Hajime Hara; Shino Usami; Yuji Kiuchi
Journal:  Mol Cell Biochem       Date:  2011-12-23       Impact factor: 3.396

9.  Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles.

Authors:  S J Peroutka; S C Price; T L Wilhoit; K W Jones
Journal:  Mol Med       Date:  1998-01       Impact factor: 6.354

10.  Evolution of haplotypes at the DRD2 locus.

Authors:  C M Castiglione; A S Deinard; W C Speed; G Sirugo; H C Rosenbaum; Y Zhang; D K Grandy; E L Grigorenko; B Bonne-Tamir; A J Pakstis
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.